Posted on 1/4/21
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
The gap between the first and booster doses of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has been widened substantially in the U.K. -- and Pfizer . . .
Posted on 1/4/21
Pfizer's Next Multibillion-Dollar COVID Vaccine Move
Pfizer (NYSE:PFE) made one of the smartest decisions in the company's long history earlier this year. It chose to partner with German biotech BioNTech (NASDAQ:BNTX) on . . .
Posted on 1/4/21
Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial?
Johnson & Johnson(NYSE:JNJ) is trailing the leaders in the coronavirus vaccine race, but the healthcare giant is approaching the finish line, thanks to cutting the size . . .
Posted on 1/4/21
Should Investors Be Worried About Pfizer and BioNTech's Coronavirus Vaccine Rollout?
In this video from Motley Fool Live, recorded on Dec. 21, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the . . .
Posted on 1/4/21
Why Teladoc Stock Soared 139% in 2020
What happenedShares of telehealth leader Teladoc Health (NYSE:TDOC) soared 139% in 2020, according to data from S&P Global Market Intelligence. That performance made it one of . . .
Posted on 1/3/21
Acorda Therapeutics Completes One-for-Six Reverse Stock Split
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares . . .
Posted on 1/3/21
New Dermatology Company Resilia Pharmaceuticals Begins Operations
Peak Pharma Commercial Partners, a New York City-based investment fund dedicated to the acquisition and growth of branded, generic and over-the-counter pharmaceutical products (www.peakpharmapartners.com). announced today . . .
Posted on 1/3/21
BrainStorm Issues 2020 Letter to Shareholders
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its Chief Executive Officer, Chaim . . .
Posted on 12/29/20
Andrew Hanna Explains the Important Role of Community Pharmacies in Distributing COVID-19 Vaccines
COVID-19 has had a damaging and disruptive effect on the Canadian people and on the country’s healthcare system. As of December 21, 2020, over 14,000 Canadians . . .
Posted on 12/24/20
Is Johnson & Johnson Stock a Buy?
Although there's a lot to like about Johnson & Johnson (NYSE:JNJ), the company still has many qualities that might keep savvy investors on the sideline. A . . .
Posted on 12/24/20
Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine
Still reeling from the coronavirus, the U.S. government has opted to double its take-up of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine. Both companies announced Wednesday . . .
Posted on 12/24/20
GBS Prices IPO
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients . . .
Posted on 12/23/20
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg?for . . .
Posted on 12/23/20
Sale of Kantar Health Kicks Off Bain Makeover
Global researcher Kantar marked its first year under the control of Bain Capital by selling off its healthcare division to healthcare IT giant Cerner.The price tag . . .
Posted on 12/23/20
Is Pfizer's COVID Vaccine Growth Story Already Over?
No matter how you look at it, Pfizer (NYSE:PFE) has had a remarkable year in 2020. The big drugmaker made a critical decision early on to . . .
Posted on 12/23/20
What Pfizer Wants You to Know About Its COVID Vaccine
Last week, some Americans began receiving their first dose of BNT162b2, the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX). Soon after the vaccine began shipping, Pfizer . . .
Posted on 12/23/20
GBS Prices of IPO
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and . . .
Posted on 12/22/20
Acorn Bioventures Invests in Cyclacel Pharmaceuticals
BERKELEY HEIGHTS, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company developing innovative medicines based on cancer cell . . .
Posted on 12/22/20
SCYNEXIS Closes of $85 Million Public Offering of Common Stock
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common . . .
Posted on 12/22/20
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology
CHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired . . .
Posted on 12/22/20
Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe
Fresh off receiving its crucial emergency use authorization (EUA) in the U.S., Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) coronavirus vaccine has received similar approval in Europe.Both companies . . .
Posted on 12/22/20
Etsy: A COVID E-Commerce Winner That Will Keep Winning In 2021
SummaryEtsy benefitted from the COVID driven e-commerce boom, but the company is well positioned for continued success in 2021.Company boasts several important competitive advantages: unique assortment . . .
Posted on 12/21/20
Provention Bio Announces Addition to NASDAQ Biotechnology Index
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has been added to the NASDAQ Biotechnology . . .
Posted on 12/21/20
Gabelli Healthcare & WellnessRx Trust Issues of $40 Million of 4.00% Series C Cumulative Preferred Shares
RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) is pleased to announce the issuance of two million 4.00% Series C . . .
Posted on 12/21/20
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Pfizer(NYSE:PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna(NASDAQ:MRNA) could soon win EUA for . . .
New York
